Published in Endocr Relat Cancer on December 01, 2000
Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia (2010) 3.93
The state of the art of the zebrafish model for toxicology and toxicologic pathology research--advantages and current limitations. Toxicol Pathol (2003) 1.79
Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells. Mol Cell Biol (2002) 1.53
Signalling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet (2006) 1.40
EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1. Genes Dev (2003) 1.37
Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci U S A (2003) 1.35
Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells. Prostate (2011) 1.34
Lefty blocks a subset of TGFbeta signals by antagonizing EGF-CFC coreceptors. PLoS Biol (2004) 1.19
Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300. Cell Signal (2008) 1.08
Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast Dis (2008) 1.03
Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells. Stem Cells (2010) 0.99
Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis. FEBS Lett (2012) 0.91
Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways. Br J Cancer (2007) 0.89
The dual role of Smad7 in the control of cancer growth and metastasis. Int J Mol Sci (2013) 0.88
Characterization of the glycosylphosphatidylinositol-anchor signal sequence of human Cryptic with a hydrophilic extension. Biochim Biophys Acta (2008) 0.87
CFC1 is a cancer stemness-regulating factor in neuroblastoma. Oncotarget (2017) 0.84
Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells. Am J Pathol (2008) 0.83
Decrypting the role of Cripto in tumorigenesis. J Clin Invest (2003) 0.81
Plasticity underlies tumor progression: role of Nodal signaling. Cancer Metastasis Rev (2016) 0.81
Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid. J Clin Endocrinol Metab (2010) 0.80
Nkx2-5 Regulates Tdgf1 (Cripto) Early During Cardiac Development. J Clin Exp Cardiolog (2012) 0.78
Intercellular transfer regulation of the paracrine activity of GPI-anchored Cripto-1 as a Nodal co-receptor. Biochem Biophys Res Commun (2010) 0.76
Tomoregulin-1 prevents cardiac hypertrophy after pressure overload in mice by inhibiting TAK1-JNK pathways. Dis Model Mech (2015) 0.75
Cripto haploinsufficiency affects in vivo colon tumor development. Int J Oncol (2014) 0.75
Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic. J Biol Chem (2017) 0.75
Tumorigenic factor CRIPTO-1 is immunolocalized in extravillous cytotrophoblast in placenta creta. Biomed Res Int (2014) 0.75
CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer. Oncogene (2017) 0.75
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol (1995) 9.03
Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation. J Exp Med (1975) 7.87
Binding of sheep red blood cells to a large population of human lymphocytes. Nature (1971) 7.67
Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem (1998) 5.99
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum (2001) 5.87
Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night. Sleep (1997) 5.82
Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood (1973) 4.99
Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J Immunol (2001) 4.38
Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med (1981) 3.93
Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G. J Exp Med (1975) 3.80
Plasma immunoglobulin concentrations in a West African (Gambian) community and in a group of healthy British adults. Clin Exp Immunol (1968) 3.53
Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J (1994) 3.42
The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord (2001) 3.39
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res (1989) 3.35
Theta-bearing and complement-receptor lymphocytes are distinct populations of cells. Science (1971) 3.16
Long-term suprapubic catheterisation: clinical outcome and satisfaction survey. Spinal Cord (1998) 3.09
HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med (1999) 3.01
Mechanism of binding of soluble immune complexes to lymphocytes. Cell Immunol (1973) 2.93
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis. Antimicrob Agents Chemother (2005) 2.74
Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med (1999) 2.58
A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory. Pediatrics (2001) 2.55
Studies on the selective lysis and purification of Trypanosoma cruzi. J Exp Med (1975) 2.54
Cell surface immunoglobulin. IV. Distribution among thymocytes, bone mrrow cells, and their derived populations. J Exp Med (1972) 2.50
Antigens associated with Plasmodium falciparum infections in man. Lancet (1969) 2.45
Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet (1987) 2.44
Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology (2003) 2.43
The induction of macrophage spreading: role of coagulation factors and the complement system. J Exp Med (1976) 2.41
Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ (1997) 2.41
Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut (2002) 2.41
Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med (1998) 2.38
Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res (1986) 2.38
Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res (1988) 2.36
Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res (1993) 2.35
Tissue localization of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. Proc Natl Acad Sci U S A (1970) 2.29
Expression of the c-erbB-2 protein in normal and transformed cells. Int J Cancer (1987) 2.27
Increased proportion of complement-receptor lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia. Blood (1972) 2.25
Family and parenting interventions for conduct disorder and delinquency: a meta-analysis of randomised controlled trials. Arch Dis Child (2002) 2.24
Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol (2000) 2.23
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. BJOG (2012) 2.14
The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis. Infect Immun (2000) 2.10
Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology (2009) 2.08
Purification and characterization of vaccinia virus growth factor. Cell (1985) 2.06
An extensive 3' cis-regulatory region directs the imaginal disk expression of decapentaplegic, a member of the TGF-beta family in Drosophila. Development (1991) 2.05
Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation (1996) 2.04
Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbeTecET. Clin Chem (1999) 2.01
Expression of the ERBB3 gene product in breast cancer. Br J Cancer (1992) 2.01
Molecular mechanisms of blood vessel formation. Trends Biochem Sci (1997) 1.93
Bladder training for urinary incontinence in adults. Cochrane Database Syst Rev (2004) 1.92
Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents. J Clin Epidemiol (1990) 1.90
Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res (1991) 1.88
Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care (2001) 1.88
Evaluation of a national surveillance unit. Arch Dis Child (1999) 1.87
A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen. Br J Cancer (2006) 1.85
Bone marrow origin of complement-receptor lymphocytes. Eur J Immunol (1971) 1.80
Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol (1997) 1.79
Family and parenting interventions in children and adolescents with conduct disorder and delinquency aged 10-17. Cochrane Database Syst Rev (2001) 1.79
Iron-induced mucosal pathology of the upper gastrointestinal tract: a common finding in patients on oral iron therapy. Histopathology (2008) 1.78
A prospective survey of the outcome of pregnancy in a rural area of the Gambia. Bull World Health Organ (1987) 1.75
Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur J Pharmacol (1999) 1.74
Screening for syphilis in pregnancy: an assessment of the costs and benefits. Community Med (1985) 1.71
Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C. J Immunol (1990) 1.70
Copper induction of laccase isoenzymes in the ligninolytic fungus Pleurotus ostreatus. Appl Environ Microbiol (2000) 1.69
Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene (1990) 1.69
Mobile elements bounded by C4A4 telomeric repeats in Oxytricha fallax. Cell (1985) 1.68
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. Endocr Relat Cancer (2003) 1.67
Effects of an oral health promotion program in people with mental illness. J Dent Res (2009) 1.67
GFRalpha3 is expressed predominantly in nociceptive sensory neurons. Eur J Neurosci (2001) 1.66
Mouse myeloma--spleen cell hybrids: Enhanced hybridization frequencies and rapid screening procedures. Curr Top Microbiol Immunol (1978) 1.66
Mutations of the epidermal growth factor receptor in non-small cell lung cancer -- search and destroy. Eur J Cancer (2006) 1.66
Immune phagocytosis in murine malaria. J Exp Med (1979) 1.66
Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet (1992) 1.66
Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology (2000) 1.64
Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers. Cancer Res (2000) 1.63
Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene (1992) 1.62
A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization. Protein Eng (1990) 1.62
Who uses the accident service? Injury (1984) 1.61
The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets (2005) 1.59
Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol (1991) 1.58
Neu receptor dimerization. Nature (1989) 1.58
Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci (2002) 1.57
Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci U S A (1993) 1.57
The epidermal growth factor receptor family. Endocr Relat Cancer (2005) 1.55
Nonarticular complication of heterotopic ossification: a clinical review. Arch Phys Med Rehabil (1991) 1.54
Observations on the treatment of an acute attack of migraine. Res Clin Stud Headache (1978) 1.53
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study. Ann Oncol (2007) 1.52
A novel white laccase from Pleurotus ostreatus. J Biol Chem (1997) 1.52
The induction of macrophage spreading by factor B of the properdin system. J Exp Med (1979) 1.50
Soluble antigens in the blood of African patients with severe plasmodium falciparum malaria. Lancet (1968) 1.50
Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J Immunol (1993) 1.50
Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J Exp Med (1998) 1.50
A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein. Mol Pharmacol (1999) 1.49
Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J Clin Invest (1996) 1.49
High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy. Endoscopy (2007) 1.49
Immunohistochemical detection of the c-erbB-2 proto-oncogene product in normal, benign and malignant cartilage tissues. Histopathology (1989) 1.48
The presentation of aggressive children and adolescents to emergency departments in Western Sydney. J Paediatr Child Health (2003) 1.48
The epidermal growth factor receptor in human pancreatic cancer. J Pathol (1992) 1.47
c-erbB-2 expression in benign and malignant breast disease. Br J Cancer (1988) 1.47
Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1. J Exp Med (1992) 1.46
The contribution of demyelination to axonal loss in multiple sclerosis. Brain (2006) 1.46